Full Text
Cabozantinib Versus Standard of Care in the first-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- A Network Meta-Analysis

Abstract

Authors

J Lister E Schmidt F Marteau A Vataire

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×